Orbimed Advisors Llc - Director, 10%+ Owner at Enliven Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type: Company
Role: Director, 10%+ Owner
Stock Symbol: ELVN on Nasdaq, IMRA on NYSE
Industry: Pharmaceutical Preparations
All Insider Reports: All Insider Reports

There are no Buy or Sell transactions made by Orbimed Advisors Llc since 11/4/2024

Holdings reported by Orbimed Advisors Llc for Enliven Therapeutics, Inc.

Security	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	7.66M	$170M	$22.14	May 16, 2024	Indirect

Transactions reported by Orbimed Advisors Llc for Enliven Therapeutics, Inc.

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.